| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9400680AGB9400680D0 (en) | 1994-01-14 | 1994-01-14 | Improvements in or relating to organic compounds |
| PE1995259309APE43595A1 (en) | 1994-01-14 | 1995-01-12 | QUINAZOLIN-2,4-DIONAS |
| IL11232095AIL112320A0 (en) | 1994-01-14 | 1995-01-12 | Quinazoline-2,4- diones, their preparation and pharmaceutical compositions containing them |
| PCT/EP1995/000136WO1995019346A1 (en) | 1994-01-14 | 1995-01-13 | Quinazoline-2,4-diones |
| ZA95269AZA95269B (en) | 1994-01-14 | 1995-01-13 | Quinazoline-2,4-diones |
| AU15341/95AAU1534195A (en) | 1994-01-14 | 1995-01-13 | Quinazoline-2,4-diones |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9400680AGB9400680D0 (en) | 1994-01-14 | 1994-01-14 | Improvements in or relating to organic compounds |
| Publication Number | Publication Date |
|---|---|
| GB9400680D0true GB9400680D0 (en) | 1994-03-09 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9400680APendingGB9400680D0 (en) | 1994-01-14 | 1994-01-14 | Improvements in or relating to organic compounds |
| Country | Link |
|---|---|
| AU (1) | AU1534195A (en) |
| GB (1) | GB9400680D0 (en) |
| IL (1) | IL112320A0 (en) |
| PE (1) | PE43595A1 (en) |
| WO (1) | WO1995019346A1 (en) |
| ZA (1) | ZA95269B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW450807B (en)* | 1995-09-15 | 2001-08-21 | Pfizer | Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents |
| CN1103772C (en)* | 1996-05-15 | 2003-03-26 | 辉瑞大药厂 | New 2,3-disubstituted-4(3H)-quinazolinones |
| GB2316616A (en)* | 1996-09-02 | 1998-03-04 | Lilly Industries Ltd | Modulation of GluR5 receptors in the hippocampus to treat psychiatric disorders |
| US6306909B1 (en) | 1997-03-12 | 2001-10-23 | Queen's University At Kingston | Anti-epileptogenic agents |
| US6627755B1 (en) | 1997-06-09 | 2003-09-30 | Pfizer Inc | Quinazolin-4-one AMPA antagonists |
| DE69831446T2 (en)* | 1997-06-09 | 2006-06-14 | Pfizer Prod Inc | Quinazolin-4-one AMPA antagonists |
| CA2444148A1 (en)* | 2001-04-11 | 2002-10-24 | Queen's University At Kingston | Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents |
| TW200403066A (en)* | 2002-04-30 | 2004-03-01 | Novartis Ag | New uses of substituted aminoalkanephosphonic acids |
| GB0416730D0 (en)* | 2004-07-27 | 2004-09-01 | Novartis Ag | Organic compounds |
| GB0507298D0 (en)* | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
| NZ586552A (en)* | 2008-01-30 | 2012-06-29 | Shin Poong Pharmaceutical Co Ltd | Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same |
| KR20120052341A (en)* | 2009-07-23 | 2012-05-23 | 노파르티스 아게 | 1h-quinazoline-2,4-diones for use in the treatment of neuronal ceroid lipofuscinosis |
| WO2011048150A1 (en)* | 2009-10-20 | 2011-04-28 | Novartis Ag | Use of 1h-quinazoline-2,4-diones |
| EP2571865A1 (en)* | 2010-05-20 | 2013-03-27 | Novartis AG | 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives |
| WO2011161249A1 (en)* | 2010-06-24 | 2011-12-29 | Novartis Ag | Use of 1h-quinazoline-2,4-diones |
| UA113280C2 (en) | 2010-11-11 | 2017-01-10 | AMINOSPIRT-SUBSTITUTED Derivatives of 2,3-Dihydroimimidase $ 1,2-c] QINAZOLINE, SUITABLE FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS, DISEASES AND DISEASES |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1068263B (en)* | 1959-11-05 | |||
| JP3381384B2 (en)* | 1994-04-30 | 2003-02-24 | 株式会社島津製作所 | Correction method for nuclear medicine imaging device |
| Publication number | Publication date |
|---|---|
| AU1534195A (en) | 1995-08-01 |
| IL112320A0 (en) | 1995-03-30 |
| WO1995019346A1 (en) | 1995-07-20 |
| PE43595A1 (en) | 1996-01-08 |
| ZA95269B (en) | 1996-07-15 |
| Publication | Publication Date | Title |
|---|---|---|
| GB9400680D0 (en) | Improvements in or relating to organic compounds | |
| GB9421984D0 (en) | Improvements in or relating to organic compounds | |
| GB9407778D0 (en) | Improvements in or relating to organic compounds | |
| GB9415786D0 (en) | Improvements in or relating to organic compounds | |
| GB9417172D0 (en) | Improvements in or relating to organic compounds | |
| GB9406289D0 (en) | Improvements in or relating to organic compounds | |
| GB9402767D0 (en) | Improvements in or relating to organic compounds | |
| GB9419348D0 (en) | Improvements in or relating to organic compounds | |
| GB9423019D0 (en) | Improvements in or relating to organic compounds | |
| GB9411150D0 (en) | Improvements in or relating to organic compounds | |
| GB9413986D0 (en) | Improvements in or relating to organic compounds | |
| GB9414287D0 (en) | Improvements in or relating to organic compounds | |
| GB9405968D0 (en) | Improvements in or relating to organic compounds | |
| GB9405966D0 (en) | Improvements in or relating to organic compounds | |
| GB9406421D0 (en) | Improvements in or relating to organic compounds | |
| GB9406585D0 (en) | Improvements in or relating to organic compounds | |
| GB9402314D0 (en) | Improvements in or relating to organic compounds | |
| GB9408000D0 (en) | Improvements in or relating to organic compounds | |
| GB9408601D0 (en) | Improvements in or relating to organic compounds | |
| GB9408905D0 (en) | Improvements in or relating to organic compounds | |
| GB9410699D0 (en) | Improvements in or relating to organic compounds | |
| GB9402313D0 (en) | Improvements in or relating to organic compounds | |
| GB9413815D0 (en) | Improvements in or relating to organic compounds | |
| GB9413985D0 (en) | Improvements in or relating to organic compounds | |
| GB9402312D0 (en) | Improvements in or relating to organic compounds |